comparemela.com

Latest Breaking News On - வன்பொன் ஆராய்ச்சி வலைப்பின்னல் - Page 1 : comparemela.com

COVID-19 Vaccine Clinical Trial Network PRN Partners with Mills Clinical Research; Expanding Services Coast-to-Coast

BlueCloud receives patent for its GDPRWallet® Trust and Verify Digital Innovation

BlueCloud receives patent for its GDPRWallet® Trust and Verify Digital Innovation Share Article Innovation enables healthcare professionals and sites to comply with modern privacy regulations while sharing third party primary source verified documents from HCPs between organizations. CEDAR PARK, Texas (PRWEB) February 23, 2021 BlueCloud® by HealthCarePoint.com, a Public Benefit Corporation, officially announced today that they’ve received a patent for its GDPRWallet® Trust and Verify application. The patent paves the way for BlueCloud’s global shareable platform, which empowers healthcare professionals to own their Personal Identifiable Information (PII), to enable third parties to verify the authenticity of the information and share that information with global organizations for business and compliance purposes. Today, more than 1.8 million healthcare and research professionals from thousands of healthcar

One Clinical Research Network, Platinum Research Network, is Changing the Game by Doubling Down on Virtual Trials

One Clinical Research Network, Platinum Research Network, is Changing the Game by Doubling Down on Virtual Trials Share Article The pharmaceutical industry is known for being dynamic and innovative when it comes to drug discovery. However, when it comes to day-to-day operations, clinical trial operations are still using DOS™. Okay, it’s not that bad. We’d like all systems to play nice. Here is how one network, Platinum Research Network, is changing the game. When the Best Sites are Necessary “It’s time. The industry is ready”, said Roth. “Many of the strategies which were being piloted before 2020 are now being implemented and followed closely for progress. We are proud to be a part of this effort. As a network, PRN has committed to new patient-centric, data-efficient solutions.

As COVID Vaccines Fast Approach for Adults, Researchers Prepare for Large-Scale Growth in Pediatrics

As COVID Vaccines Fast Approach for Adults, Researchers Prepare for Large-Scale Growth in Pediatrics Share Article Pediatric vaccine development has been one of the fastest growing areas in clinical research prior to the COVID-19 pandemic. Platinum Research Network has been actively supporting Phase I-III COVID-19 vaccine trials in adults and is fully prepared for upcoming trials in pediatric age groups. These trials are necessary to efficiently bring life-changing vaccines to the market. Platinum Research Network Kip McKenzie, President of Tekton Research, states, “Through the strength and collaborative relationships with Sponsors and CRO’s and extensive experience with enrollment of pediatric studies, we are prepared to successfully enroll pediatric COVID-19 trials.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.